Hosameldin Bebars, MD
Hospitalist · Fredericksburg, VANPI 1922431550
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Johnson & Johnson at 27.8% of the total. Reporting peaked in 2023 at $245 and has fallen 74.1% since, to $64 in 2025. Among hospitalist clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$258
- AstraZeneca$109
- Paratek Pharmaceuticals, Inc.$83
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$68
- Novo Nordisk$54
- Baxter Healthcare$41
- plus $315 from 12 others
What the payments were for
- Food & beverage$927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$927 in reported general payments places this provider in the 90th percentile of 539 hospitalist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $12,484 |
| Gabapentin | 61 | $1,140 |
| Cefpodoxime Proxetil | 13 | $500 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $307 |
| Quetiapine Fumarate | 15 | $305 |
| Tramadol Hcl | 28 | $273 |
| Methocarbamol | 21 | $256 |
| Doxycycline Hyclate | 23 | $198 |
| Pantoprazole Sodium | 32 | $194 |
| Levofloxacin | 15 | $192 |
| Atorvastatin Calcium | 14 | $180 |
| Cefdinir | 25 | $178 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $163 |
| Cephalexin | 20 | $154 |
| Amlodipine Besylate | 44 | $137 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Fredericksburg
- Roya QaemiFredericksburg$2K
- Zalmai AfzaliFredericksburg$2K
- Paulo Andres Torres-LopezFredericksburg$1K
- Imran AhmadFredericksburg$1K
- Hammad HafeezFredericksburg$1K
- Feroz TamanaFredericksburg$1K
- Rahel DagneFredericksburg$985
- Muhammad AsifFredericksburg$941
- Barbara NewbergFredericksburg$710
- Mustafa SaidiFredericksburg$654
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.